EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Suppression of HIV-TAT and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters

B Celia Cui, Marina Aksenova, Aliaksandra Sikirzhytskaya, Diana Odhiambo, Elizaveta Korunova, Vitali Sikirzhytski, Hao Ji, Diego Altomare, Eugenia Broude, Norma Frizzell, Rosemarie Booze, Michael D Wyatt und 1 weitere

Journal of NeuroVirology · 2024

DOI: 10.1007/s13365-024-01216-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of NeuroVirology, 2024. Verfasst von B Celia Cui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, 29208, USA. Hauptthemen laut MEDLINE: Succinates, Microglia, Cocaine, Carboxy-Lyases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIGMS NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-associated neurological disorder (HAND) is a serious complication of HIV infection marked by neurotoxicity induced by viral proteins like Tat. Substance abuse exacerbates neurocognitive impairment in people living with HIV. There is an urgent need for therapeutic strategies to combat HAND comorbid with Cocaine Use Disorder (CUD). Our analysis of HIV and cocaine-induced transcriptomes in primary cortical cultures revealed significant overexpression of the macrophage-specific gene aconitate decarboxylase 1 (Acod1). The ACOD1 protein converts the tricarboxylic acid intermediate cis-aconitate into itaconate during the activation of inflammation. Itaconate then facilitates cytokine production and activates anti-inflammatory transcription factors, shielding macrophages from infection-induced cell death. However, the immunometabolic function of itaconate was unexplored in HIV and cocaine-exposed microglia. We assessed the potential of 4-octyl-itaconate (4OI), a cell-penetrable ester form of itaconate known for its anti-inflammatory properties. When primary cortical cultures exposed to Tat and cocaine were treated with 4OI, microglial cell number increased and the morphological altercations induced by Tat and cocaine were reversed. Microglial cells also appeared more ramified, resembling the quiescent microglia. 4OI treatment inhibited secretion of the proinflammatory cytokines IL-1α, IL-1β, IL-6, and MIP1-α induced by Tat and cocaine. Transcriptome profiling determined that Nrf2 target genes were significantly activated in Tat and 4OI treated cultures relative to Tat alone. Further, genes associated with cytoskeleton dynamics in inflammatory microglia were downregulated by 4OI treatment. Together, the results strongly suggest 4-octyl-itaconate holds promise as a potential candidate for therapeutic development to treat HAND coupled with CUD comorbidities. Graphical Abstract Model of 4OI-mediated neuroprotection against Tat-Cocaine toxicity. Tat and Tat-Cocaine treatment induce neuronal damage, which is mitigated by 4OI through microglia cells. This cartoon shows the reduction of harmful effects such as pro-inflammatory cytokine release, upregulation of P2R, PDE, and Acod1 by the presence of 4OI. This ester modified itaconate triggers anti-inflammatory responses and activates antioxidant pathways

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SuccinatesMicrogliaCocaineCarboxy-LyasesNF-E2-Related Factor 2tat Gene Products, Human Immunodeficiency VirusAnimalsHumansInflammationHIV InfectionsCells, CulturedCocaine-Related DisordersCytokinesRatsNeurotoxicity SyndromesPrimary Cell CultureGene Expression Regulation

Stichwörter der Autor:innen

Acod 1HANDHIVItaconateMicrogliaNeuroinflammationTat

Substanzen

SuccinatesCocaineCarboxy-LyasesNF-E2-Related Factor 2tat Gene Products, Human Immunodeficiency Virus4-octyl itaconateACOD1 protein, humanitaconic acidCytokinesNFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, 29208, USA.
  • Department of Pharmacology, Physiology and Neuroscience, School of Medicine, University of South Carolina, Columbia, SC, 29208, USA.
  • Department of Psychology, College of Arts and Sciences, University of South Carolina, Columbia, SC, 29208, USA.
  • Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, 29208, USA. shtutmanm@cop.sc.edu.

ORCID-Profile: Michael Shtutman

Förderung

  • NIDA NIH HHS
  • NIGMS NIH HHS
  • National Institute on Drug Abuse
  • National Institute of General Medical Sciences
  • University of South Carolina

Zitieren

APA

Cui, B. C., Aksenova, M., Sikirzhytskaya, A., Odhiambo, D., Korunova, E., Sikirzhytski, V., Ji, H., Altomare, D., Broude, E., Frizzell, N., Booze, R., Wyatt, M. D., & Shtutman, M. (2024). Suppression of HIV-TAT and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters. Journal of NeuroVirology. https://doi.org/10.1007/s13365-024-01216-9

Vancouver

Cui BC, Aksenova M, Sikirzhytskaya A, Odhiambo D, Korunova E, Sikirzhytski V, et al. Suppression of HIV-TAT and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters. Journal of NeuroVirology. 2024. doi:10.1007/s13365-024-01216-9

BibTeX
@article{Cui2024,
  author = {Cui, B Celia and Aksenova, Marina and Sikirzhytskaya, Aliaksandra and Odhiambo, Diana and Korunova, Elizaveta and Sikirzhytski, Vitali and Ji, Hao and Altomare, Diego and Broude, Eugenia and Frizzell, Norma and Booze, Rosemarie and Wyatt, Michael D and Shtutman, Michael},
  title = {Suppression of HIV-TAT and cocaine-induced neurotoxicity and inflammation by cell penetrable itaconate esters},
  journal = {Journal of NeuroVirology},
  year = {2024},
  doi = {10.1007/s13365-024-01216-9}
}
Kostenlos starten →